Demecan has signed major supply agreements for medicinal cannabis flowers with Little Green Pharma (Denmark), Safricanna (South Africa), and Atlas Growers (Canada). Over the next few years, Demecan will be supplied exclusively with at least six different medical cannabis flowers from these three suppliers. Deliveries will begin this year, subject to regulatory and licensing requirements. The combined amount will be over 2.2 tons of dried cannabis flower in the first year of delivery alone.
Photo by Demecan
Demecan is Germany’s leading medical cannabis company and the only independent German company to have been awarded the contract by the Federal Institute for Drugs and Medical Devices (BfArM) to grow, process, and distribute medical cannabis in
Germany. In April, Demecan delivered for the first time from its domestically cultivated cannabis flowers directly to the BfArM. To guarantee the security of supply for patients in Germany, Demecan also works as a pharmaceutical wholesaler with cannabis producers worldwide and imports medical cannabis.
By expanding its supplier network, Demecan will continue to lead the way in providing patients with the highest quality medical cannabis products and, at the same time, diversifies its supplier network for the upcoming legalization of adult-use cannabis in Germany. This allows Demecan to further consolidate its position as the go-to
company for medical cannabis and, at the same time, provides a possible advantage for the future adult-use cannabis market in Germany.
For more information:
Demecan
[email protected]
www.demecan.de